Notably, NK cell activity on melanoma tumor growth was improved, when IL-33-activated ILC2s were depleted [94], because they strongly upregulated CD73 ecto-enzyme which, in vivo, suppress T and NK cell functions by upregulating the suppressive adenosine in TME. This evidence concerns the gene IL33 and neoplasm.